Bluejay Diagnostics, Inc. (BJDX) Free cash flow 2021–2025
Bluejay Diagnostics, Inc. (BJDX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.2MFY2025 · since FY2021: -$4.4M → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | +23.4% |
| FY2024 | -$8.1M | +9.9% |
| FY2023 | -$9.0M | -0.9% |
| FY2022 | -$8.9M | -103.6% |
| FY2021 | -$4.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice